Story perspectives
TrumpRx Launch Delayed Amid Legal and Oversight Concerns
1/31/2026
1 of 1
Story summary
- U.S. President Donald Trump postponed the launch of TrumpRx, a platform to purchase discounted prescription drugs directly from pharmaceutical companies.
- Senator Richard J. Durbin (D-Ill.), Senator Elizabeth Warren (D-Mass.), and Senator Peter Welch (D-Vt.) pressed questions about legality and oversight, contributing to the delay.
- The Department of Health and Human Services has not responded to Congress's oversight requests, and details on how TrumpRx will operate remain unclear.
